It really should be no surprise (I hope) that the lay press failed to capture what it is about this case that is unique or useful. Please bear with me as I make an attempt.
It is common for recipients to develop some degree of chimerism post liver transplant. The liver is a site of hematopoiesis (production of blood) although to a much smaller degree than the bone marrow, so it contains the same kinds of cells that are involved in bone marrow transplants. Usually the chimerism in liver transplant is transient and does not persist. Even if it does persist, the immunosuppressive drugs also have the effect of suppressing the donor immune reactions, so they are not given the opportunity fully replace the recipient's immune system.
What was unusual in this case, is that the degree of engraftment (establishment of the hematopoietic cells) was much greater - more like what is seen with bone marrow transplant. It is hypothesized that the reason for this was due to the young age of the donor (12) and the recipient (9). The dose of the hematopoietic cells was larger than you would receive from an older liver, and other factors related to both the acute illness that led to transplant and an acute CMV infection post-transplant meant that the recipients own population of immune cells was dramatically reduced (a natural version of the destruction of the immune system that is done purposely prior to a bone marrow transplant).
A war developed between her few remaining immune cells and the blood cells of the recipient. Because she had such an unusually large degree of engraftment, this was a war that the donor cells could actually win. For that reason, her immunosuppressive therapy was discontinued and the donor cells essentially eliminated her remaining immune system.
This case is unique (as far as I know) in the particular combination of events and that processes that previously were deliberately induced in others happened on their own. It is not unique because doctors have never seen these processes before or cannot come up with a plausible explanation.
This issue of the NEJM contained 3 reports on a variety of patients that were able to come off of immunosuppressive drugs due to this sort of chimerism, and an editorial from Thomas Starzl (one of the main players in the field of transplantation) discussing the implications. It is important because it helps solidify hypotheses/theories on how and why some people are able to survive without immunosuppressive therapy. And it also lends credence to the promotion of alternate methods that have been used or are undergoing experimental development, of dealing with rejection.
Linda